The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies.
Kaidar-Person O, Boersma LJ, De Brouwer P, Weltens C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Peters M, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Bartelink H, Struikmans H, Fortpied C, Poortmans PM; EORTC Radiation Oncology and Breast Cancer Groups.
Kaidar-Person O, et al.
Radiother Oncol. 2024 Dec;201:110563. doi: 10.1016/j.radonc.2024.110563. Epub 2024 Sep 26.
Radiother Oncol. 2024.
PMID: 39341505
Clinical Trial.
Surgery for the primary tumour and axillary lymph nodes, chest wall RT, boost RT after whole breast RT in breast conserving therapy (BCT), RT to operated axilla, and systemic therapy were per physician's preference. ...OS was worse with mastectomy as compared to BCT and wi …
Surgery for the primary tumour and axillary lymph nodes, chest wall RT, boost RT after whole breast RT in breast conserving therapy ( …